Cargando…
Molecular characterization of Cryptosporidium isolates from humans in Ontario, Canada
BACKGROUND: Cryptosporidiosis is a gastrointestinal disease with global distribution. It has been a reportable disease in Canada since 2000; however, routine molecular surveillance is not conducted. Therefore, sources of contamination are unknown. The aim of this project was to identify species and...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821412/ https://www.ncbi.nlm.nih.gov/pubmed/33482898 http://dx.doi.org/10.1186/s13071-020-04546-9 |
_version_ | 1783639418510245888 |
---|---|
author | Guy, Rebecca A. Yanta, Christine A. Muchaal, Pia K. Rankin, Marisa A. Thivierge, Karine Lau, Rachel Boggild, Andrea K. |
author_facet | Guy, Rebecca A. Yanta, Christine A. Muchaal, Pia K. Rankin, Marisa A. Thivierge, Karine Lau, Rachel Boggild, Andrea K. |
author_sort | Guy, Rebecca A. |
collection | PubMed |
description | BACKGROUND: Cryptosporidiosis is a gastrointestinal disease with global distribution. It has been a reportable disease in Canada since 2000; however, routine molecular surveillance is not conducted. Therefore, sources of contamination are unknown. The aim of this project was to identify species and subtypes of Cryptosporidium in clinical cases from Ontario, the largest province in Canada, representing one third of the Canadian population, in order to understand transmission patterns. METHODS: A total of 169 frozen, banked, unpreserved stool specimens that were microscopy positive for Cryptosporidium over the period 2008–2017 were characterized using molecular tools. A subset of the 169 specimens were replicate samples from individual cases. DNA was extracted directly from the stool and nested PCR followed by Sanger sequencing was conducted targeting the small subunit ribosomal RNA (SSU) and glycoprotein 60 (gp60) genes. RESULTS: Molecular typing data and limited demographic data were obtained for 129 cases of cryptosporidiosis. Of these cases, 91 (70.5 %) were due to Cryptosporidium parvum and 24 (18.6%) were due to Cryptosporidium hominis. Mixed infections of C. parvum and C. hominis occurred in four (3.1%) cases. Five other species observed were Cryptosporidium ubiquitum (n = 5), Cryptosporidium felis (n = 2), Cryptosporidium meleagridis (n = 1), Cryptosporidium cuniculus (n = 1) and Cryptosporidium muris (n = 1). Subtyping the gp60 gene revealed 5 allelic families and 17 subtypes of C. hominis and 3 allelic families and 17 subtypes of C. parvum. The most frequent subtype of C. hominis was IbA10G2 (22.3%) and of C. parvum was IIaA15G2R1 (62.4%). CONCLUSIONS: The majority of isolates in this study were C. parvum, supporting the notion that zoonotic transmission is the main route of cryptosporidiosis transmission in Ontario. Nonetheless, the observation of C. hominis in about a quarter of cases suggests that anthroponotic transmission is also an important contributor to cryptosporidiosis pathogenesis in Ontario. [Image: see text] |
format | Online Article Text |
id | pubmed-7821412 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-78214122021-01-22 Molecular characterization of Cryptosporidium isolates from humans in Ontario, Canada Guy, Rebecca A. Yanta, Christine A. Muchaal, Pia K. Rankin, Marisa A. Thivierge, Karine Lau, Rachel Boggild, Andrea K. Parasit Vectors Research BACKGROUND: Cryptosporidiosis is a gastrointestinal disease with global distribution. It has been a reportable disease in Canada since 2000; however, routine molecular surveillance is not conducted. Therefore, sources of contamination are unknown. The aim of this project was to identify species and subtypes of Cryptosporidium in clinical cases from Ontario, the largest province in Canada, representing one third of the Canadian population, in order to understand transmission patterns. METHODS: A total of 169 frozen, banked, unpreserved stool specimens that were microscopy positive for Cryptosporidium over the period 2008–2017 were characterized using molecular tools. A subset of the 169 specimens were replicate samples from individual cases. DNA was extracted directly from the stool and nested PCR followed by Sanger sequencing was conducted targeting the small subunit ribosomal RNA (SSU) and glycoprotein 60 (gp60) genes. RESULTS: Molecular typing data and limited demographic data were obtained for 129 cases of cryptosporidiosis. Of these cases, 91 (70.5 %) were due to Cryptosporidium parvum and 24 (18.6%) were due to Cryptosporidium hominis. Mixed infections of C. parvum and C. hominis occurred in four (3.1%) cases. Five other species observed were Cryptosporidium ubiquitum (n = 5), Cryptosporidium felis (n = 2), Cryptosporidium meleagridis (n = 1), Cryptosporidium cuniculus (n = 1) and Cryptosporidium muris (n = 1). Subtyping the gp60 gene revealed 5 allelic families and 17 subtypes of C. hominis and 3 allelic families and 17 subtypes of C. parvum. The most frequent subtype of C. hominis was IbA10G2 (22.3%) and of C. parvum was IIaA15G2R1 (62.4%). CONCLUSIONS: The majority of isolates in this study were C. parvum, supporting the notion that zoonotic transmission is the main route of cryptosporidiosis transmission in Ontario. Nonetheless, the observation of C. hominis in about a quarter of cases suggests that anthroponotic transmission is also an important contributor to cryptosporidiosis pathogenesis in Ontario. [Image: see text] BioMed Central 2021-01-22 /pmc/articles/PMC7821412/ /pubmed/33482898 http://dx.doi.org/10.1186/s13071-020-04546-9 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Guy, Rebecca A. Yanta, Christine A. Muchaal, Pia K. Rankin, Marisa A. Thivierge, Karine Lau, Rachel Boggild, Andrea K. Molecular characterization of Cryptosporidium isolates from humans in Ontario, Canada |
title | Molecular characterization of Cryptosporidium isolates from humans in Ontario, Canada |
title_full | Molecular characterization of Cryptosporidium isolates from humans in Ontario, Canada |
title_fullStr | Molecular characterization of Cryptosporidium isolates from humans in Ontario, Canada |
title_full_unstemmed | Molecular characterization of Cryptosporidium isolates from humans in Ontario, Canada |
title_short | Molecular characterization of Cryptosporidium isolates from humans in Ontario, Canada |
title_sort | molecular characterization of cryptosporidium isolates from humans in ontario, canada |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821412/ https://www.ncbi.nlm.nih.gov/pubmed/33482898 http://dx.doi.org/10.1186/s13071-020-04546-9 |
work_keys_str_mv | AT guyrebeccaa molecularcharacterizationofcryptosporidiumisolatesfromhumansinontariocanada AT yantachristinea molecularcharacterizationofcryptosporidiumisolatesfromhumansinontariocanada AT muchaalpiak molecularcharacterizationofcryptosporidiumisolatesfromhumansinontariocanada AT rankinmarisaa molecularcharacterizationofcryptosporidiumisolatesfromhumansinontariocanada AT thiviergekarine molecularcharacterizationofcryptosporidiumisolatesfromhumansinontariocanada AT laurachel molecularcharacterizationofcryptosporidiumisolatesfromhumansinontariocanada AT boggildandreak molecularcharacterizationofcryptosporidiumisolatesfromhumansinontariocanada |